合并亚临床型甲状腺功能减退的骨质疏松症62例患者骨代谢及骨转换标志物水平分析

doi:10.6040/j.issn.1671-7554.0.2019.1391

摘要/Abstract

摘要： 目的分析骨转换标志物血清1型胶原羧基端肽(β-CTX)和血清1型前胶原氨基端前肽(PINP)在亚临床型甲状腺功能减退(简称亚甲减)合并骨质疏松症患者中的表达,并探讨其能否作为判断该类患者骨质疏松程度及脆性骨折发生风险的预测指标。方法选取2016年7月至2019年6月收治的骨质疏松症合并亚甲减患者62例(骨松甲减组),以及同期收治的单纯骨质疏松症伴骨痛患者65例(骨松骨痛组),并纳入同年龄段健康体检者68例(正常对照组)。比较3组间骨代谢标志物,如血钙、血磷、血镁、碱性磷酸酶、25羟维生素D、骨密度、T值、甲状腺激素、甲状旁腺素以及骨转换标志物血清PINP及β-CTX浓度水平。结果骨松甲减组、骨松骨痛组及正常对照组骨代谢及骨转换标志物中血钙、血磷、血镁、碱性磷酸酶、甲状旁腺素水平差异无统计学意义(P均>0.05),而25羟维生素D、骨密度、T值、β-CTX及PINP水平差异有统计学意义(P均<0.05)。结论骨松甲减组PINP、β-CTX水平降低,为低转换型骨质疏松,不能依靠骨转换标志物作为骨松甲减组骨质疏松程度的判断指标及预测骨折发生风险。

关键词: 骨质疏松症, 亚临床型甲状腺功能减退症, 骨密度, 骨转换标志物, 血清1型前胶原氨基端前肽, 血清1型胶原羧基端肽

Abstract: Objective To analyze the expressions of type 1 collagen cross-linked C-telopeptide(β-CTX)and N-terminal propeptide of type 1 precollagen(PINP)in osteoporosis patients with subclinical hypothyroidism, and to investigate whether these bone turnover markers(BTMs)can be used as predictors of the degree of osteoporosis and the risk of brittle fracture. Methods A total of 62 patients of osteoporosis with subclinical hypothyroidism admitted during July 2016 and June 2019 were selected as the research subjects, 65 patients of osteoporosis with ostalgia admitted at the same period were enrolled as the ostalgia group, and 68 healthy people who received physical examination during the same period served as healthy controls. Bone metabolism markers including calcium, phosphorus, magnesium, alkaline phosphatase, 25 hydroxyvitamin D, bone mineral density, T value, thyroid hormone, parathyroid hormone and serum PINP 山东大学学报 (医学版)58卷5期 -康成为,等.合并亚临床型甲状腺功能减退的骨质疏松症62例患者骨代谢及骨转换标志物水平分析 \=-and β-CTX levels were compared among the three groups. Results There were no significant differences in the levels of serum calcium, phosphorus, magnesium, alkaline phosphatase and parathyroid hormone among the three groups(all P>0.05)while significant differences in 25 hydroxyvitamin D, bone mineral density, T value, β-CTX and PINP levels were detected(all P<0.05). Conclusion The levels of PINP and β-CTX decreased in osteoporosis patients with subclinical hypothyroidism. Such cases are low conversion osteoporosis, and BTMs cannot be used to evaluate the degree of osteoporosis or predict the risk of fracture.

Key words: Osteoporosis, Subclinical hypothyroidism, Bone mineral density, Bone turnover markers, N-terminal propeptide of type 1 precollagen, Type 1 collagen cross-linked C-telopeptide

中图分类号:

R581.2

康成为,刘雷,蒲小兵,谭钢,董长超,晏兆魁. 合并亚临床型甲状腺功能减退的骨质疏松症62例患者骨代谢及骨转换标志物水平分析[J]. 山东大学学报 (医学版), 2020, 58(5): 82-86.

KANG Chengwei, LIU Lei, PU Xiaobing, TAN Gang, DONG Changchao, YAN Zhaokui. Analysis of bone metabolism and bone turnover markers in 62 cases of osteoporosis with subclinical hypothyroidism[J]. Journal of Shandong University (Health Sciences), 2020, 58(5): 82-86.

参考文献

[1] Lorentzon M, Cummings SR. Osteoporosis: the evolution of a diagnosis [J]. J Intern Med, 2015, 277(6): 650-661.
[2] Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis [J]. Lancet Diabetes Endocrinol, 2017, 5(11): 908-923.
[3] Finigan J, Greenfield DM, Blumsohn A, et al. Risk factors for vertebral and nonvertebral fracture over 10 years: a population-based study in women [J]. J Bone Miner Res, 2008, 23(1): 75-85.
[4] Vasikaran S, Eastell R, Bruyère O, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards [J]. Osteoporos Int, 2011, 22(2): 391-420.
[5] Lorentzon M, Branco J, Brandi ML, et al. Algorithm for the use of biochemical markers of bone turnover in the diagnosis, assessment and follow-up of treatment for osteoporosis[J]. Adv Ther, 2019, 36(10): 2811-2824.
[6] Tian A, Ma J, Feng K, et al. Reference markers of bone turnover for prediction of fracture: a meta-analysis [J]. J Orthop Surg Res, 2019, 14(1): 68.
[7] Hernandez AV, Pérez-López FR, Piscoya A, et al. Comparative efficacy of bone anabolic therapies in women with postmenopausal osteoporosis: A systematic review and network meta-analysis of randomized controlled trials [J]. Maturitas, 2019, 129: 12-22. doi: 10.1016/j.maturitas.
[8] Diez-Perez A, Naylor KE, Abrahamsen B, et al. International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates [J]. Osteoporos Int, 2017, 28(3): 767-774.
[9] Naylor KE, Jacques RM, Paggiosi M, et al. Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study [J]. Osteoporos Int, 2016, 27(1): 21-31.
[10] 刘海春, 张剑锋, 陈允震. 骨质疏松大鼠股骨生物力学特性与骨胶原质量变化的相关研究[J]. 山东大学学报(医学版), 2009, 47(5): 42-45. LIU Haichun, ZHANG Jianfeng, CHEN Yunzhen. Bone collagen and biomechanical propertyies in the femur of osteoporosis rats [J]. Journal of Shandong University(Health Sciences), 2009, 47(5): 42-45.
[11] 徐大霞, 侯楠, 李晓峰, 等. 糖皮质激素性骨质疏松症骨代谢与糖皮质激素用药时间的相关性[J]. 山东大学学报(医学版), 2017, 55(5): 103-107. XU Daxia, HOU Nan, LI Xiaofeng, et al. Relevance between bone metabolism of glucocorticoid-induced osteoporosis and duration of glucocorticoid treatment[J]. Journal of Shandong University(Health Sciences), 2017, 55(5): 103-107.
[12] Wang XY, Hua BX, Jiang C, et al. Serum biomarkers related to glucocorticoid-induced osteonecrosis of the femoral head: a prospective nested Case-control study [J]. J Orthop Res, 2019, 37(11): 2348-2357.
[13] Johansson H, Odén A, Kanis JA, et al. A meta-analysis of reference markers of bone turnover for prediction of fracture [J]. Calcif Tissue Int, 2014, 94(5): 560-567.
[14] Choi H, Ryu KY, Roh J, et al. Effect of radioactive iodine-induced hypothyroidism on longitudinal bone growth during puberty in immature female rats [J]. Exp Anim, 2018, 67(4): 395-401.
[15] Chawla J, Sharma N, Arora D, et al. Bone densitometry status and its associated factors in peri and post menopausal females: A cross sectional study from a tertiary care centre in India [J]. Taiwan J Obstet Gynecol, 2018, 57(1): 100-105.
[16] Sefati N, Norouzian M, Abbaszadeh HA, et al. Effects of bone marrow mesenchymal stem cells-conditioned medium on tibial partial osteotomy model of fracture healing in hypothyroidism rats [J]. Iran Biomed J, 2018, 22(2): 90-98.
[17] Konca Degertekin C, Turhan Iyidir O, Aktas Yilmaz B, et al. RANKL/Osteoprotegerin system and bone turnover in hashimoto thyroiditis[J]. Calcif Tissue Int, 2016, 99(4): 365-372.
[18] Abe E, Marians RC, Yu W, et al. TSH is a negative regulator of skeletal remodeling [J]. Cell, 2003, 115(2): 151-162.

相关文章 15

[1]	陈诗鸿,姜冬青,庄向华,李晓博,潘喆,孙爱丽,娄能俊,王殿辉,杜娇娇,宋玉文. 以骨痛为首发表现的原发性胆汁性胆管炎1例[J]. 山东大学学报 (医学版), 2022, 60(8): 98-102.
[2]	邢小平. 原发性骨质疏松症诊治思考[J]. 山东大学学报 (医学版), 2021, 59(6): 1-4.
[3]	刘萍,宋玉文,王萍,田光伟,郑凤杰,吕丽,杜娇娇,张静,庄向华,陈诗鸿. 维生素D缺乏与2型糖尿病合并抑郁状态的相关性[J]. 山东大学学报 (医学版), 2021, 59(6): 51-56,102.
[4]	杜娇娇,庄向华,陈诗鸿,王雪萌,姜冬青,吴菲,韩晓琳,华梦羽,宋玉文. 绝经后骨质疏松症患者血清IL-31、IL-33表达变化[J]. 山东大学学报 (医学版), 2021, 59(6): 45-50.
[5]	陈诗鸿. 糖皮质激素性骨质疏松症研究进展[J]. 山东大学学报 (医学版), 2021, 59(6): 33-37.
[6]	李娜,张志勉. 138例39~81岁体检人员血管钙化指标的关联分析[J]. 山东大学学报 (医学版), 2020, 58(2): 85-89.
[7]	徐大霞,侯楠,李晓峰,王闯,孔猛,焦广俊,陈允震. 糖皮质激素性骨质疏松症骨代谢与糖皮质激素用药时间的相关性[J]. 山东大学学报（医学版）, 2017, 55(5): 103-107.
[8]	张婧,郝兰香,张晓晨,张永红,范珊珊,刘燕,蒋玲. 双酚A对大鼠椎体及股骨骨密度的影响[J]. 山东大学学报（医学版）, 2016, 54(3): 36-40.
[9]	张丽, 严红. 2型糖尿病患者骨质疏松情况调查[J]. 山东大学学报（医学版）, 2014, 52(S2): 107-107.
[10]	胡苏1,2，逄曙光2，崔莹2，于春晓1，赵家军1，管庆波1. 链脲佐菌素诱导糖尿病大鼠骨髓间充质干细胞成骨分化[J]. 山东大学学报(医学版), 2013, 51(8): 7-12.
[11]	张洪美1，王燕2，康东红1，曹维1，刘涛1，王萍1. 济南市城区健康成年男性腰椎和股骨的骨密度分析[J]. 山东大学学报(医学版), 2013, 51(4): 67-70.
[12]	成开花1，张立新2. 促性腺激素释放激素激动剂治疗子宫内膜异位症对性激素及骨密度的影响及处理方法[J]. 山东大学学报(医学版), 2012, 50(3): 83-86.
[13]	刘梅1，张君2，王旭霞3. T1DM、T2DM糖尿病大鼠牙槽骨骨密度变化的相关性实验研究[J]. 山东大学学报(医学版), 2011, 49(9): 53-.
[14]	丁岩，陈允震，刘海春，陈剑，赵华，王洪亮，焦广俊. 指数曲线电刺激治疗原发性骨质疏松[J]. 山东大学学报(医学版), 2010, 48(3): 70-73.
[15]	张磊,李牧,祁磊,蔡中续,李玉华,孙元亮. 晚期糖基化终末产物在糖尿病大鼠骨质疏松发病中的作用及胰岛素潜在的防护机制[J]. 山东大学学报(医学版), 2007, 45(11): 1148-1152.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed